ReP USP - Resultado da busca

Artigo de periodico
Impact of sample heterogeneity on the evaluation of uncertainty from sampling and analytical steps in pharmaceutical analysis (2025)
Crivilari, Victória Aparecida Vit; Santos, Jean Bispo dos; Lourenço, Felipe Rebello
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF
Subjects: FÁRMACOS, ANTI-INFLAMATÓRIOS, MEDIÇÃO DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIVILARI, Victória Aparecida Vit e SANTOS, Jean Bispo dos e LOURENÇO, Felipe Rebello. Impact of sample heterogeneity on the evaluation of uncertainty from sampling and analytical steps in pharmaceutical analysis. Journal of Pharmaceutical and Biomedical Analysis, v. 255, p. 1-7 art. 116660, 2025Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jpba.2025.116660. Acesso em: 15 jun. 2025.
APA
Crivilari, V. A. V., Santos, J. B. dos, & Lourenço, F. R. (2025). Impact of sample heterogeneity on the evaluation of uncertainty from sampling and analytical steps in pharmaceutical analysis. Journal of Pharmaceutical and Biomedical Analysis, 255, 1-7 art. 116660. doi:10.1016/j.jpba.2025.116660
NLM
Crivilari VAV, Santos JB dos, Lourenço FR. Impact of sample heterogeneity on the evaluation of uncertainty from sampling and analytical steps in pharmaceutical analysis [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2025 ; 255 1-7 art. 116660.[citado 2025 jun. 15 ] Available from: https://dx.doi.org/10.1016/j.jpba.2025.116660
Vancouver
Crivilari VAV, Santos JB dos, Lourenço FR. Impact of sample heterogeneity on the evaluation of uncertainty from sampling and analytical steps in pharmaceutical analysis [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2025 ; 255 1-7 art. 116660.[citado 2025 jun. 15 ] Available from: https://dx.doi.org/10.1016/j.jpba.2025.116660
Artigo de periodico
Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment (2024)
Passarin, Paula Beatriz Silva ; Lourenço, Felipe Rebello
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF
Subjects: INDÚSTRIA FARMACÊUTICA, CROMATOGRAFIA LÍQUIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASSARIN, Paula Beatriz Silva e LOURENÇO, Felipe Rebello. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment. Journal of Pharmaceutical and Biomedical Analysis, v. 239, p. 1-12, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jpba.2023.115907. Acesso em: 15 jun. 2025.
APA
Passarin, P. B. S., & Lourenço, F. R. (2024). Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment. Journal of Pharmaceutical and Biomedical Analysis, 239, 1-12. doi:10.1016/j.jpba.2023.115907
NLM
Passarin PBS, Lourenço FR. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 239 1-12.[citado 2025 jun. 15 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115907
Vancouver
Passarin PBS, Lourenço FR. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 239 1-12.[citado 2025 jun. 15 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115907
Artigo de periodico
Measurement uncertainty for < 905 > Uniformity of Dosage Units tests using Monte Carlo and bootstrapping methods – Uncertainties arising from sampling and analytical steps (2024)
Martins, Maisa Torres; Lourenço, Felipe Rebello
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF
Subjects: MEDICAMENTO, MÉTODO DE MONTE CARLO, MEDIÇÃO DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS, Maisa Torres e LOURENÇO, Felipe Rebello. Measurement uncertainty for < 905 > Uniformity of Dosage Units tests using Monte Carlo and bootstrapping methods – Uncertainties arising from sampling and analytical steps. Journal of Pharmaceutical and Biomedical Analysis, v. 238, p. 1-8 art. 115857, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jpba.2023.115857. Acesso em: 15 jun. 2025.
APA
Martins, M. T., & Lourenço, F. R. (2024). Measurement uncertainty for < 905 > Uniformity of Dosage Units tests using Monte Carlo and bootstrapping methods – Uncertainties arising from sampling and analytical steps. Journal of Pharmaceutical and Biomedical Analysis, 238, 1-8 art. 115857. doi:10.1016/j.jpba.2023.115857
NLM
Martins MT, Lourenço FR. Measurement uncertainty for < 905 > Uniformity of Dosage Units tests using Monte Carlo and bootstrapping methods – Uncertainties arising from sampling and analytical steps [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 238 1-8 art. 115857.[citado 2025 jun. 15 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115857
Vancouver
Martins MT, Lourenço FR. Measurement uncertainty for < 905 > Uniformity of Dosage Units tests using Monte Carlo and bootstrapping methods – Uncertainties arising from sampling and analytical steps [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 238 1-8 art. 115857.[citado 2025 jun. 15 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115857
Artigo de periodico
Development and optimization of stability-indicating method of ethinylestradiol, levonorgestrel, and their main impurities using quality by design approach (2023)
Silva, Fernando Antunes da ; Lourenço, Felipe Rebello ; Calixto, Leandro Augusto
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF
Subjects: CROMATOGRAFIA LÍQUIDA DE ALTA EFICIÊNCIA, MÉTODO DE MONTE CARLO, FÁRMACOS (SISTEMA REPRODUTOR)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Fernando Antunes da e LOURENÇO, Felipe Rebello e CALIXTO, Leandro Augusto. Development and optimization of stability-indicating method of ethinylestradiol, levonorgestrel, and their main impurities using quality by design approach. Journal of Pharmaceutical and Biomedical Analysis, v. 225, p. 1-14 art. 115208, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2022.115208. Acesso em: 15 jun. 2025.
APA
Silva, F. A. da, Lourenço, F. R., & Calixto, L. A. (2023). Development and optimization of stability-indicating method of ethinylestradiol, levonorgestrel, and their main impurities using quality by design approach. Journal of Pharmaceutical and Biomedical Analysis, 225, 1-14 art. 115208. doi:10.1016/j.jpba.2022.115208
NLM
Silva FA da, Lourenço FR, Calixto LA. Development and optimization of stability-indicating method of ethinylestradiol, levonorgestrel, and their main impurities using quality by design approach [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2023 ; 225 1-14 art. 115208.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2022.115208
Vancouver
Silva FA da, Lourenço FR, Calixto LA. Development and optimization of stability-indicating method of ethinylestradiol, levonorgestrel, and their main impurities using quality by design approach [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2023 ; 225 1-14 art. 115208.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2022.115208
Artigo de periodico
A new application of the switchable hydrophilicity solvent-based homogenous liquid–liquid microextraction to analyze synthetic cannabinoids in plasma by LC-MS/MS (2023)
Fabris, André Luis ; Martins, Aline Franco; Costa, Jose Luiz ; Yonamine, Maurício
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF
Subjects: CANABINOIDES, PLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FABRIS, André Luis et al. A new application of the switchable hydrophilicity solvent-based homogenous liquid–liquid microextraction to analyze synthetic cannabinoids in plasma by LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis, v. 234, p. 1-11 art. 115588, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2023.115588. Acesso em: 15 jun. 2025.
APA
Fabris, A. L., Martins, A. F., Costa, J. L., & Yonamine, M. (2023). A new application of the switchable hydrophilicity solvent-based homogenous liquid–liquid microextraction to analyze synthetic cannabinoids in plasma by LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis, 234, 1-11 art. 115588. doi:10.1016/j.jpba.2023.115588
NLM
Fabris AL, Martins AF, Costa JL, Yonamine M. A new application of the switchable hydrophilicity solvent-based homogenous liquid–liquid microextraction to analyze synthetic cannabinoids in plasma by LC-MS/MS [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2023 ; 234 1-11 art. 115588.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2023.115588
Vancouver
Fabris AL, Martins AF, Costa JL, Yonamine M. A new application of the switchable hydrophilicity solvent-based homogenous liquid–liquid microextraction to analyze synthetic cannabinoids in plasma by LC-MS/MS [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2023 ; 234 1-11 art. 115588.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2023.115588
Artigo de periodico
Definition of multivariate acceptance limits (guard-bands) applied to pharmaceutical equivalence assessment (2023)
Silva, Cintia Margueiro da; Lourenço, Felipe Rebello
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF
Subjects: MEDICAMENTO, MEDIÇÃO DE RISCO, ANÁLISE MULTIVARIADA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Cintia Margueiro da e LOURENÇO, Felipe Rebello. Definition of multivariate acceptance limits (guard-bands) applied to pharmaceutical equivalence assessment. Journal of Pharmaceutical and Biomedical Analysis, v. 222, p. 1-7 art. 115080, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2022.115080. Acesso em: 15 jun. 2025.
APA
Silva, C. M. da, & Lourenço, F. R. (2023). Definition of multivariate acceptance limits (guard-bands) applied to pharmaceutical equivalence assessment. Journal of Pharmaceutical and Biomedical Analysis, 222, 1-7 art. 115080. doi:10.1016/j.jpba.2022.115080
NLM
Silva CM da, Lourenço FR. Definition of multivariate acceptance limits (guard-bands) applied to pharmaceutical equivalence assessment [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2023 ; 222 1-7 art. 115080.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2022.115080
Vancouver
Silva CM da, Lourenço FR. Definition of multivariate acceptance limits (guard-bands) applied to pharmaceutical equivalence assessment [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2023 ; 222 1-7 art. 115080.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2022.115080
Artigo de periodico
Updating the use of nano-biosensors as promising devices for the diagnosis of coronavirus family members: a systematic review (2022)
Aquino, Adriano; Paschoalin, Vania Margaret Flosi; Tessaro, Leticia Louize Gonçalves; Raymundo-Pereira, Paulo Augusto ; Conte-Junior, Carlos Adam
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: IFSC
Subjects: SENSOR, CORONAVIRUS, COVID-19, NANOTECNOLOGIA, SENSORES BIOMÉDICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AQUINO, Adriano et al. Updating the use of nano-biosensors as promising devices for the diagnosis of coronavirus family members: a systematic review. Journal of Pharmaceutical and Biomedical Analysis, v. 211, p. 114608-1-114608-10, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2022.114608. Acesso em: 15 jun. 2025.
APA
Aquino, A., Paschoalin, V. M. F., Tessaro, L. L. G., Raymundo-Pereira, P. A., & Conte-Junior, C. A. (2022). Updating the use of nano-biosensors as promising devices for the diagnosis of coronavirus family members: a systematic review. Journal of Pharmaceutical and Biomedical Analysis, 211, 114608-1-114608-10. doi:10.1016/j.jpba.2022.114608
NLM
Aquino A, Paschoalin VMF, Tessaro LLG, Raymundo-Pereira PA, Conte-Junior CA. Updating the use of nano-biosensors as promising devices for the diagnosis of coronavirus family members: a systematic review [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2022 ; 211 114608-1-114608-10.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2022.114608
Vancouver
Aquino A, Paschoalin VMF, Tessaro LLG, Raymundo-Pereira PA, Conte-Junior CA. Updating the use of nano-biosensors as promising devices for the diagnosis of coronavirus family members: a systematic review [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2022 ; 211 114608-1-114608-10.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2022.114608
Artigo de periodico
Determination of misoprostol acid in plasma samples by UPLC–MS/MS with application in a maternal-fetal pharmacokinetic study following a low misoprostol dose vaginally to induce labor (2021)
Filgueira, Gabriela Campos de Oliveira; Rodrigues, Grazielle de Fátima Pinto; Benzi, Jhohann Richard de Lima ; Nardotto, Glauco Henrique Balthazar ; Marques, Maria Paula ; Lanchote, Vera Lucia ; Cavalli, Ricardo de Carvalho
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Subjects: TRABALHO DE PARTO INDUZIDO, PROSTAGLANDINAS SINTÉTICAS, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, GRAVIDEZ, HEMORRAGIA, PLACENTA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FILGUEIRA, Gabriela Campos de Oliveira et al. Determination of misoprostol acid in plasma samples by UPLC–MS/MS with application in a maternal-fetal pharmacokinetic study following a low misoprostol dose vaginally to induce labor. Journal of Pharmaceutical and Biomedical Analysis, v. 202, p. 1-7, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2021.114138. Acesso em: 15 jun. 2025.
APA
Filgueira, G. C. de O., Rodrigues, G. de F. P., Benzi, J. R. de L., Nardotto, G. H. B., Marques, M. P., Lanchote, V. L., & Cavalli, R. de C. (2021). Determination of misoprostol acid in plasma samples by UPLC–MS/MS with application in a maternal-fetal pharmacokinetic study following a low misoprostol dose vaginally to induce labor. Journal of Pharmaceutical and Biomedical Analysis, 202, 1-7. doi:10.1016/j.jpba.2021.114138
NLM
Filgueira GC de O, Rodrigues G de FP, Benzi JR de L, Nardotto GHB, Marques MP, Lanchote VL, Cavalli R de C. Determination of misoprostol acid in plasma samples by UPLC–MS/MS with application in a maternal-fetal pharmacokinetic study following a low misoprostol dose vaginally to induce labor [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2021 ; 202 1-7.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2021.114138
Vancouver
Filgueira GC de O, Rodrigues G de FP, Benzi JR de L, Nardotto GHB, Marques MP, Lanchote VL, Cavalli R de C. Determination of misoprostol acid in plasma samples by UPLC–MS/MS with application in a maternal-fetal pharmacokinetic study following a low misoprostol dose vaginally to induce labor [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2021 ; 202 1-7.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2021.114138
Artigo de periodico
Ligand screening assay for the enzyme kallikrein immobilized on NHS-activated Sepharose (2021)
Carvalho, Daniella Romano de ; Ximenes, Valdecir Farias; Groppo, Milton ; Cardoso, Carmen Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FFCLRP
Subjects: ENZIMAS, ENSAIO CLÍNICO, LIGANTES, CALICREINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Daniella Romano de et al. Ligand screening assay for the enzyme kallikrein immobilized on NHS-activated Sepharose. Journal of Pharmaceutical and Biomedical Analysis, v. 199, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2021.114026. Acesso em: 15 jun. 2025.
APA
Carvalho, D. R. de, Ximenes, V. F., Groppo, M., & Cardoso, C. L. (2021). Ligand screening assay for the enzyme kallikrein immobilized on NHS-activated Sepharose. Journal of Pharmaceutical and Biomedical Analysis, 199. doi:10.1016/j.jpba.2021.114026
NLM
Carvalho DR de, Ximenes VF, Groppo M, Cardoso CL. Ligand screening assay for the enzyme kallikrein immobilized on NHS-activated Sepharose [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2021 ; 199[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2021.114026
Vancouver
Carvalho DR de, Ximenes VF, Groppo M, Cardoso CL. Ligand screening assay for the enzyme kallikrein immobilized on NHS-activated Sepharose [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2021 ; 199[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2021.114026
Artigo de periodico
A validated HPLC-UV method for the analysis of phenolic compounds in Brazilian red propolis and Dalbergia ecastaphyllum (2021)
Aldana Mejía, Jennyfer Andrea ; Ccana-Ccapatinta, Gari V.; Ribeiro, Victor Pena ; Arruda, Caroline; Veneziani, Rodrigo C. S; Ambrósio, Sérgio Ricardo; Bastos, Jairo Kenupp
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCFRP
Subjects: ISOFLAVONAS, CROMATOGRAFIA, VALIDADE DO TESTE, PRÓPOLIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALDANA MEJÍA, Jennyfer Andrea et al. A validated HPLC-UV method for the analysis of phenolic compounds in Brazilian red propolis and Dalbergia ecastaphyllum. Journal of Pharmaceutical and Biomedical Analysis, v. 198, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2021.114029. Acesso em: 15 jun. 2025.
APA
Aldana Mejía, J. A., Ccana-Ccapatinta, G. V., Ribeiro, V. P., Arruda, C., Veneziani, R. C. S., Ambrósio, S. R., & Bastos, J. K. (2021). A validated HPLC-UV method for the analysis of phenolic compounds in Brazilian red propolis and Dalbergia ecastaphyllum. Journal of Pharmaceutical and Biomedical Analysis, 198. doi:10.1016/j.jpba.2021.114029
NLM
Aldana Mejía JA, Ccana-Ccapatinta GV, Ribeiro VP, Arruda C, Veneziani RCS, Ambrósio SR, Bastos JK. A validated HPLC-UV method for the analysis of phenolic compounds in Brazilian red propolis and Dalbergia ecastaphyllum [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2021 ; 198[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2021.114029
Vancouver
Aldana Mejía JA, Ccana-Ccapatinta GV, Ribeiro VP, Arruda C, Veneziani RCS, Ambrósio SR, Bastos JK. A validated HPLC-UV method for the analysis of phenolic compounds in Brazilian red propolis and Dalbergia ecastaphyllum [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2021 ; 198[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2021.114029
Artigo de periodico
Risk of false pharmaceutical equivalence (non-equivalence) decisions due to measurement uncertainty (2021)
Bertanha, Maria Luiza de Godoy; Lourenço, Felipe Rebello
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF
Subjects: MEDICAMENTO, MEDIÇÃO DE RISCO, BIOEQUIVALÊNCIA, QUALIDADE DOS MEDICAMENTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERTANHA, Maria Luiza de Godoy e LOURENÇO, Felipe Rebello. Risk of false pharmaceutical equivalence (non-equivalence) decisions due to measurement uncertainty. Journal of Pharmaceutical and Biomedical Analysis, v. 204, p. 1-9 art. 114269, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2021.114269. Acesso em: 15 jun. 2025.
APA
Bertanha, M. L. de G., & Lourenço, F. R. (2021). Risk of false pharmaceutical equivalence (non-equivalence) decisions due to measurement uncertainty. Journal of Pharmaceutical and Biomedical Analysis, 204, 1-9 art. 114269. doi:10.1016/j.jpba.2021.114269
NLM
Bertanha ML de G, Lourenço FR. Risk of false pharmaceutical equivalence (non-equivalence) decisions due to measurement uncertainty [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2021 ; 204 1-9 art. 114269.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2021.114269
Vancouver
Bertanha ML de G, Lourenço FR. Risk of false pharmaceutical equivalence (non-equivalence) decisions due to measurement uncertainty [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2021 ; 204 1-9 art. 114269.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2021.114269
Artigo de periodico
Stability-indicating method development for quantification of bromopride, its impurities, and degradation products by ultra-high performance liquid chromatography applying Analytical Quality by Design principles (2021)
Abreu, Juliana Caldeira; Mahr, Amanda Guiraldelli; Lago, Claudimir Lucio do
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: IQ
Subjects: CROMATOGRAFIA LÍQUIDA, QUIMIOMETRIA, MÉTODO DE MONTE CARLO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABREU, Juliana Caldeira e MAHR, Amanda Guiraldelli e LAGO, Claudimir Lucio do. Stability-indicating method development for quantification of bromopride, its impurities, and degradation products by ultra-high performance liquid chromatography applying Analytical Quality by Design principles. Journal of Pharmaceutical and Biomedical Analysis, v. 205, p. 1-9 art. 114306, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2021.114306. Acesso em: 15 jun. 2025.
APA
Abreu, J. C., Mahr, A. G., & Lago, C. L. do. (2021). Stability-indicating method development for quantification of bromopride, its impurities, and degradation products by ultra-high performance liquid chromatography applying Analytical Quality by Design principles. Journal of Pharmaceutical and Biomedical Analysis, 205, 1-9 art. 114306. doi:10.1016/j.jpba.2021.114306
NLM
Abreu JC, Mahr AG, Lago CL do. Stability-indicating method development for quantification of bromopride, its impurities, and degradation products by ultra-high performance liquid chromatography applying Analytical Quality by Design principles [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2021 ; 205 1-9 art. 114306.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2021.114306
Vancouver
Abreu JC, Mahr AG, Lago CL do. Stability-indicating method development for quantification of bromopride, its impurities, and degradation products by ultra-high performance liquid chromatography applying Analytical Quality by Design principles [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2021 ; 205 1-9 art. 114306.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2021.114306
Artigo de periodico
Antidepressants determination using an electroanalytical approach: a review of methods (2021)
Martins, Fernanda C. O. L ; Pimenta, Laura C; Souza, Djenaine de
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: ESALQ
Subjects: ANTIDEPRESSIVOS, ELETROANÁLISE, ELETRODO, VOLTAMETRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS, Fernanda C. O. L e PIMENTA, Laura C e SOUZA, Djenaine de. Antidepressants determination using an electroanalytical approach: a review of methods. Journal of Pharmaceutical and Biomedical Analysis, v. 206, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2021.114365. Acesso em: 15 jun. 2025.
APA
Martins, F. C. O. L., Pimenta, L. C., & Souza, D. de. (2021). Antidepressants determination using an electroanalytical approach: a review of methods. Journal of Pharmaceutical and Biomedical Analysis, 206. doi:10.1016/j.jpba.2021.114365
NLM
Martins FCOL, Pimenta LC, Souza D de. Antidepressants determination using an electroanalytical approach: a review of methods [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2021 ; 206[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2021.114365
Vancouver
Martins FCOL, Pimenta LC, Souza D de. Antidepressants determination using an electroanalytical approach: a review of methods [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2021 ; 206[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2021.114365
Artigo de periodico
Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio (2020)
Pippa, Leandro Francisco ; Oliveira, Milena Locci de ; Rocha, Adriana; Andrade, Jurandyr Moreira de ; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Subjects: ANTINEOPLÁSICOS, FARMACOCINÉTICA, VARIAÇÃO (BIOLOGIA), NEOPLASIAS MAMÁRIAS, MIOCARDIOPATIA CONGESTIVA, QUIMIOTERAPIA, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIPPA, Leandro Francisco et al. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio. Journal of Pharmaceutical and Biomedical Analysis, v. 185, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2020.113231. Acesso em: 15 jun. 2025.
APA
Pippa, L. F., Oliveira, M. L. de, Rocha, A., Andrade, J. M. de, & Lanchote, V. L. (2020). Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio. Journal of Pharmaceutical and Biomedical Analysis, 185. doi:10.1016/j.jpba.2020.113231
NLM
Pippa LF, Oliveira ML de, Rocha A, Andrade JM de, Lanchote VL. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 185[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2020.113231
Vancouver
Pippa LF, Oliveira ML de, Rocha A, Andrade JM de, Lanchote VL. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 185[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2020.113231
Artigo de periodico
Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia (2020)
Oliveira, Milena Locci de ; Rocha, Adriana; Nardotto, Glauco Henrique Balthazar ; Pippa, Leandro Francisco ; Simões, Belinda Pinto ; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, ANTINEOPLÁSICOS, METABÓLITOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Milena Locci de et al. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia. Journal of Pharmaceutical and Biomedical Analysis, v. 191, p. 1-8, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2020.113576. Acesso em: 15 jun. 2025.
APA
Oliveira, M. L. de, Rocha, A., Nardotto, G. H. B., Pippa, L. F., Simões, B. P., & Lanchote, V. L. (2020). Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia. Journal of Pharmaceutical and Biomedical Analysis, 191, 1-8. doi:10.1016/j.jpba.2020.113576
NLM
Oliveira ML de, Rocha A, Nardotto GHB, Pippa LF, Simões BP, Lanchote VL. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 191 1-8.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2020.113576
Vancouver
Oliveira ML de, Rocha A, Nardotto GHB, Pippa LF, Simões BP, Lanchote VL. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 191 1-8.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2020.113576
Artigo de periodico
Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers (2020)
Cestari, Roberta Natália ; Caris, Juciene Aparecida ; Rocha, Adriana; Nardotto, Glauco Henrique Balthazar ; Oliveira, Renê Donizeti Ribeiro de; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Subjects: ESTATINAS, FARMACOCINÉTICA, FARMACOLOGIA, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, COMPOSTOS ORGÂNICOS, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESTARI, Roberta Natália et al. Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers. Journal of Pharmaceutical and Biomedical Analysis, v. 182, p. 1-7, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2020.113128. Acesso em: 15 jun. 2025.
APA
Cestari, R. N., Caris, J. A., Rocha, A., Nardotto, G. H. B., Oliveira, R. D. R. de, & Lanchote, V. L. (2020). Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers. Journal of Pharmaceutical and Biomedical Analysis, 182, 1-7. doi:10.1016/j.jpba.2020.113128
NLM
Cestari RN, Caris JA, Rocha A, Nardotto GHB, Oliveira RDR de, Lanchote VL. Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 182 1-7.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2020.113128
Vancouver
Cestari RN, Caris JA, Rocha A, Nardotto GHB, Oliveira RDR de, Lanchote VL. Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 182 1-7.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2020.113128
Artigo de periodico
Frequentist approach for estimation of false decision risks in conformity assessment based on measurement uncertainty of liquid chromatography analytical procedures (2020)
Separovic, Luciana ; Lourenço, Felipe Rebello
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF
Assunto: CROMATOGRAFIA LÍQUIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEPAROVIC, Luciana e LOURENÇO, Felipe Rebello. Frequentist approach for estimation of false decision risks in conformity assessment based on measurement uncertainty of liquid chromatography analytical procedures. Journal of Pharmaceutical and Biomedical Analysis, v. 184, p. 1-7 art. 113203, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2020.113203. Acesso em: 15 jun. 2025.
APA
Separovic, L., & Lourenço, F. R. (2020). Frequentist approach for estimation of false decision risks in conformity assessment based on measurement uncertainty of liquid chromatography analytical procedures. Journal of Pharmaceutical and Biomedical Analysis, 184, 1-7 art. 113203. doi:10.1016/j.jpba.2020.113203
NLM
Separovic L, Lourenço FR. Frequentist approach for estimation of false decision risks in conformity assessment based on measurement uncertainty of liquid chromatography analytical procedures [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 184 1-7 art. 113203.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2020.113203
Vancouver
Separovic L, Lourenço FR. Frequentist approach for estimation of false decision risks in conformity assessment based on measurement uncertainty of liquid chromatography analytical procedures [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 184 1-7 art. 113203.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2020.113203
Artigo de periodico
A new approach for identifying antagonism among fungi species and antifungal activity (2020)
Silva, Airton Damasceno; Ambrozin, Alessandra Regina Pepe; Carneiro, Renato Lajarim; Vieira, Paulo Cezar
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCFRP
Subjects: ANTIFÚNGICOS, QUIMIOMETRIA, EXTRATOS (FORMAS FARMACÊUTICAS), FUNGICIDAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Airton Damasceno et al. A new approach for identifying antagonism among fungi species and antifungal activity. Journal of Pharmaceutical and Biomedical Analysis, v. 179, p. 1-11, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2019.112960. Acesso em: 15 jun. 2025.
APA
Silva, A. D., Ambrozin, A. R. P., Carneiro, R. L., & Vieira, P. C. (2020). A new approach for identifying antagonism among fungi species and antifungal activity. Journal of Pharmaceutical and Biomedical Analysis, 179, 1-11. doi:10.1016/j.jpba.2019.112960
NLM
Silva AD, Ambrozin ARP, Carneiro RL, Vieira PC. A new approach for identifying antagonism among fungi species and antifungal activity [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 179 1-11.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2019.112960
Vancouver
Silva AD, Ambrozin ARP, Carneiro RL, Vieira PC. A new approach for identifying antagonism among fungi species and antifungal activity [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 179 1-11.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2019.112960
Artigo de periodico
Effect of light, oxygen and temperature on the stability of artepillin C and p-coumaric acid from Brazilian green propolis (2020)
Arruda, Caroline; Ribeiro, Victor Pena ; Almeida, Marília Oliveira; Mejía, Jennyfer Andrea Aldana; Casoti, Rosana; Bastos, Jairo Kenupp
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCFRP
Subjects: PRÓPOLIS, ESTABILIDADE DOS MEDICAMENTOS, CONTROLE DA QUALIDADE, COMPOSTOS FENÓLICOS, FARMACOLOGIA, ARMAZENAGEM DE MEDICAMENTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARRUDA, Caroline et al. Effect of light, oxygen and temperature on the stability of artepillin C and p-coumaric acid from Brazilian green propolis. Journal of Pharmaceutical and Biomedical Analysis, v. 178, p. 1-8, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2019.112922. Acesso em: 15 jun. 2025.
APA
Arruda, C., Ribeiro, V. P., Almeida, M. O., Mejía, J. A. A., Casoti, R., & Bastos, J. K. (2020). Effect of light, oxygen and temperature on the stability of artepillin C and p-coumaric acid from Brazilian green propolis. Journal of Pharmaceutical and Biomedical Analysis, 178, 1-8. doi:10.1016/j.jpba.2019.112922
NLM
Arruda C, Ribeiro VP, Almeida MO, Mejía JAA, Casoti R, Bastos JK. Effect of light, oxygen and temperature on the stability of artepillin C and p-coumaric acid from Brazilian green propolis [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 178 1-8.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2019.112922
Vancouver
Arruda C, Ribeiro VP, Almeida MO, Mejía JAA, Casoti R, Bastos JK. Effect of light, oxygen and temperature on the stability of artepillin C and p-coumaric acid from Brazilian green propolis [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 178 1-8.[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2019.112922
Artigo de periodico
Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study (2020)
Moreira, Fernanda de Lima ; Marques, Maria Paula ; Duarte, Geraldo ; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FMRP, FCFRP
Subjects: FÁRMACOS, ANTIRRETROVIRAIS, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Fernanda de Lima et al. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis, v. 177, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2019.112838. Acesso em: 15 jun. 2025.
APA
Moreira, F. de L., Marques, M. P., Duarte, G., & Lanchote, V. L. (2020). Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis, 177. doi:10.1016/j.jpba.2019.112838
NLM
Moreira F de L, Marques MP, Duarte G, Lanchote VL. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 177[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2019.112838
Vancouver
Moreira F de L, Marques MP, Duarte G, Lanchote VL. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 177[citado 2025 jun. 15 ] Available from: https://doi.org/10.1016/j.jpba.2019.112838

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration